Filana Therapeutics (FLNA) Financials: Revenue & Earnings
FLNA$0.65-0.00 -0.15%
$31.27M
Market Cap
—
P/E
—
Forward P/E
—
Score
Filana Therapeutics (FLNA) Financials: Revenue & Earnings
FLNA price $0.65 -0.00 -0.15%
- Ticker
- FLNA
- Price
- $0.65
- Change
- -0.00 -0.15%
- Market cap ?
- $31.27M
- Beta ?
- -0.66
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
FLNA fair value Not meaningful. Price $0.65.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.24 | — | — |
| 2026-07-29 | -0.18 | -0.23 | — | — |
| 2026-05-07 | -0.21 | -0.23 | — | — |
| 2026-03-12 | -0.26 | -0.30 | — | — |
| 2025-11-12 | -0.22 | -0.27 | — | — |
| 2025-08-14 | -0.92 | — | — | — |
| 2025-05-08 | -0.48 | — | — | — |
| 2025-03-03 | -0.57 | -0.58 | — | — |
| 2024-11-07 | -0.58 | -0.73 | — | — |
| 2024-08-08 | 0.13 | -0.41 | — | — |
| 2024-05-10 | -0.43 | -0.46 | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Barry Richard | Buy | 100.00K | $0.92 | 92.00K |
| 2026-09-29 | Barry Richard | Buy | 206.81K | $0.90 | 186.13K |
| 2026-09-28 | Barry Richard | Buy | 93.09K | $0.84 | 78.20K |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Filana Therapeutics, Inc. (FLNA) trades at $0.65, with a market cap of $31.27M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn